These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8649318

  • 1. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Kaspers GJ, Veerman AJ, Popp-Snijders C, Lomecky M, Van Zantwijk CH, Swinkels LM, Van Wering ER, Pieters R.
    Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana D.
    J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
    [Abstract] [Full Text] [Related]

  • 5. BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
    Haarman EG, Kaspers GJ, Pieters R, van Zantwijk CH, Broekema GJ, Hählen K, Veerman AJ.
    Adv Exp Med Biol; 1999 Aug; 457():325-33. PubMed ID: 10500808
    [Abstract] [Full Text] [Related]

  • 6. Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.
    Styczyński J, Wysocki M, Debski R, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk J, Wachowiak J, Sońta-Jakimczyk D, Chybicka A.
    Acta Biochim Pol; 2002 Aug; 49(1):93-8. PubMed ID: 12136961
    [Abstract] [Full Text] [Related]

  • 7. Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
    Hegge IR, Kaspers GJ, Rots MG, Jansen G, Pieters R, Veerman AJ.
    Adv Exp Med Biol; 1999 Aug; 457():551-5. PubMed ID: 10500833
    [Abstract] [Full Text] [Related]

  • 8. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J, Wysocki M, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk A, Wachowiak J, Sońta-Jakimczyk D, Chybicka A.
    Neoplasma; 2002 Aug; 49(3):178-83. PubMed ID: 12098004
    [Abstract] [Full Text] [Related]

  • 9. Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
    Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hählen K, Van Wering ER.
    Leuk Res; 1995 Mar; 19(3):175-81. PubMed ID: 7700079
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
    Kaspers GJ, Veerman AJ, Van Wering ER, Van Der Linden-Schrever BE, Van Zantwijk CH, Van Der Does-Van Den Berg A, Pieters R.
    Leukemia; 1996 Apr; 10(4):675-81. PubMed ID: 8618446
    [Abstract] [Full Text] [Related]

  • 11. Circumvention of glucocorticoid resistance in childhood leukemia.
    Haarman EG, Kaspers GJ, Pieters R, Rottier MM, Veerman AJ.
    Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
    [Abstract] [Full Text] [Related]

  • 12. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
    Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, de Waal FC, van Wering ER, Veerman AJ.
    Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616
    [Abstract] [Full Text] [Related]

  • 13. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM.
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.
    Maung ZT, Reid MM, Matheson E, Taylor PR, Proctor SJ, Hall AG.
    Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
    Styczynski J, Kurylak A, Wysocki M.
    Anticancer Res; 2005 Sep; 25(3B):2253-8. PubMed ID: 16158972
    [Abstract] [Full Text] [Related]

  • 16. Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
    Zheng C, Liu X, Wu J, Cai X, Zhu W, Sun Z.
    Am J Hematol; 2010 Oct; 85(10):817-8. PubMed ID: 20815080
    [Abstract] [Full Text] [Related]

  • 17. Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.
    Chen SH, Yang CP, Jaing TH, Hung IJ, Shih LY, Ho PC, Lee WI, Huang JL.
    Leuk Lymphoma; 2012 Aug; 53(8):1536-42. PubMed ID: 22260162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
    Mihál V, Hajdúch M, Nosková V, Feketová G, Jess K, Gojová L, Kaspárek I, Starý J, Blazek B, Pospísilová D, Novák Z.
    Adv Exp Med Biol; 1999 Aug; 457():461-71. PubMed ID: 10500823
    [Abstract] [Full Text] [Related]

  • 20. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
    Ramsey LB, Janke LJ, Payton MA, Cai X, Paugh SW, Karol SE, Kamdem Kamdem L, Cheng C, Williams RT, Jeha S, Pui CH, Evans WE, Relling MV.
    PLoS One; 2015 Aug; 10(8):e0135134. PubMed ID: 26252865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.